Connect with us

Life Sciences

Gene Writing and Rewriting: The Key to Unlocking its Full Potential

Join us for this GEN webinar on the latest gene writing and gene rewriting advancements. Our distinguished guests, Grigoriy Sterin from Tessera and Dr….

Published

on

This article was originally published by GEN Genetic Engineering and Biotechnology News

Broadcast Date: April 27, 2023
Time: 8:00 am PT, 11:00 am ET, 17:00 CET

Despite its promise, gene writing poses several challenges that must be addressed. This includes the need to accelerate analysis pipelines to deliver results faster or make these pipelines accessible to scientific users who may not have experience with complex computing infrastructure. Additionally, improving cloud resource use efficiency is crucial to perform large-scale analyses without breaking the bank. Fortunately, bioinformatic tools like Nextflow and Nextflow Tower can help overcome these challenges by making pipelines exceptionally easy to launch, monitor, and analyze results—saving time at all stages in the data analysis workflow.

Join us for this GEN webinar on the latest gene writing and gene rewriting advancements. Our distinguished guests, Grigoriy Sterin and Dr. Evan Floden will explore these developments, providing insight into how to unlock the full potential of gene writing through better management practices. In addition, these revolutionary techniques can potentially treat and cure diseases at their source by identifying promising protein and DNA signatures through RNAseq and other pipelines. Don’t miss out on this opportunity to learn about the future of genetic medicine.

A live Q&A session will follow the presentation, offering you a chance to pose questions to our expert panelists.

Grigoriy Sterin
Grigoriy Sterin
Senior Principal Engineer
Tessera Therapeutics
Evan Floden
Evan Floden, PhD
CEO & Co-founder
Seqera Labs

seqera logo

The post Gene Writing and Rewriting: The Key to Unlocking its Full Potential appeared first on GEN – Genetic Engineering and Biotechnology News.

Life Sciences

Wittiest stocks:: Avalo Therapeutics Inc (NASDAQ:AVTX 0.00%), Nokia Corp ADR (NYSE:NOK 0.90%)

There are two main reasons why moving averages are useful in forex trading: moving averages help traders define trend recognize changes in trend. Now well…

Continue Reading
Markets

Spellbinding stocks: LumiraDx Limited (NASDAQ:LMDX 4.62%), Transocean Ltd (NYSE:RIG -2.67%)

There are two main reasons why moving averages are useful in forex trading: moving averages help traders define trend recognize changes in trend. Now well…

Continue Reading
Life Sciences

Asian Fund for Cancer Research announces Degron Therapeutics as the 2023 BRACE Award Venture Competition Winner

The Asian Fund for Cancer Research (AFCR) is pleased to announce that Degron Therapeutics was selected as the winner of the 2023 BRACE Award Venture Competition….

Continue Reading

Trending